Home/Filings/4/0001209191-23-042654
4//SEC Filing

Coulie Bernard 4

Accession 0001209191-23-042654

CIK 0001746473other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 7:14 PM ET

Size

6.3 KB

Accession

0001209191-23-042654

Insider Transaction Report

Form 4
Period: 2023-07-14
Coulie Bernard
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    2023-07-14+137,500412,253 total
Holdings
  • Common Stock

    (indirect: See footnote)
    409,317
Footnotes (2)
  • [F1]On July 28, 2022, the Reporting Person was granted 275,000 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On July 14, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 137,500 shares.
  • [F2]Shares are held by The Coulie/Leyman Family Trust. The Reporting Person and his spouse serve as trustees for the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for the purposes of Section 16 or for any other purpose.

Issuer

PLIANT THERAPEUTICS, INC.

CIK 0001746473

Entity typeother

Related Parties

1
  • filerCIK 0001808895

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 7:14 PM ET
Size
6.3 KB